1. Home/
  2. Compounds/
  3. tretinoin:navitoclax (4:1 mol/mol)

tretinoin:navitoclax (4:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2tretinoin:navitoclax (4:1 mol/mol)
PharmacoGx tretinoin:navitoclax (4:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to tretinoin:navitoclax (4:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ADORA2A CTRPv2 pan-cancer AAC -0.11 0.003
mRNA MYO1G CTRPv2 pan-cancer AAC 0.12 0.003
mRNA AC141272.1 CTRPv2 pan-cancer AAC 0.1 0.003
mRNA FNDC5 CTRPv2 pan-cancer AAC 0.11 0.003
mRNA SERTM1 CTRPv2 pan-cancer AAC 0.11 0.003
mRNA CLIC6 CTRPv2 pan-cancer AAC 0.1 0.003
mRNA NCOA2 CTRPv2 pan-cancer AAC 0.11 0.003
mRNA VSX2 CTRPv2 pan-cancer AAC 0.1 0.003
mRNA PDIA6 CTRPv2 pan-cancer AAC -0.11 0.003
mRNA DGKE CTRPv2 pan-cancer AAC 0.11 0.003
Download CSV